Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): - PowerPoint PPT Presentation

1 / 62
About This Presentation
Title:

Platelets for Neonatal Transfusion Study 2 (PlaNeT-2):

Description:

Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): A randomised controlled trial of platelet transfusion thresholds – PowerPoint PPT presentation

Number of Views:335
Avg rating:3.0/5.0
Slides: 63
Provided by: nbs78
Category:

less

Transcript and Presenter's Notes

Title: Platelets for Neonatal Transfusion Study 2 (PlaNeT-2):


1
Platelets for Neonatal Transfusion Study 2
(PlaNeT-2) A randomised controlled trial of
platelet transfusion thresholds
2
Neonatal Thrombocytopenia Current Practice
  • Current national transfusion guidance based on
    consensus rather than evidence
  • British Committee for Standards in Haematology
    (2004)
  • United Kingdom Blood Services (2007)
  • Survey in the UK showed wide variation in
    platelet transfusion practice
  • Chaudhary and Clarke (2008)

3
PlaNeT-2
  • Platelets for Neonatal Transfusion - Study 2

4
PlaNeT-2 Study design (I)
  • Two-stage, randomised, parallel group,
    superiority trial.
  • Aim to compare two different platelet count
    thresholds for prophylactic platelet transfusion
    to preterm neonates.
  • Primary Outcome
  • Proportion of patients who either die or
    experience a major bleed up to and including
    study day 28.

5
PlaNeT-2 Study design (II)
  • Secondary Outcomes
  • Proportion of neonates surviving to home
    following a major bleed
  • Mortality prior to day 28
  • Major bleeds by day 28
  • Platelets transfused to study day 28
  • Length of hospital stay
  • Transfusion-related adverse events
  • Neuro-developmental outcome

6
PlaNeT-2 Choosing platelet thresholds
  • Last RCT done by Andrew et al (1993) assessed
  • 50-150x109/L vs. gt150x109/L
  • PlaNeT-1 (2009)
  • Most transfusions given at platelets 1050x109/L.
  • 50th and 90th centile pre-transfusion platelet
    counts 27 and 48x109/L.
  • 42 transfusions lt25x109/L and 92 lt50x109/L

7
PlaNeT-2 Platelet thresholds
  • Arm A Standard transfuse platelets at lt25x109/L
  • (330 neonates)
  • Arm B Intervention transfuse platelets at
    lt50x109/L
  • (330 neonates)
  • Dose 15 ml/kg

8
PlaNeT-2 Additional platelet transfusions
  • May be considered under the following
    circumstances
  • Therapeutically to treat moderate, major or
    severe bleeding but not for minor bleeding.
  • Prior to planned invasive procedures as below
    only
  • Suprapubic aspiration
  • Lumbar puncture
  • Major surgery where haemostasis may be critical
    to outcome.

9
Modified WHO Bleeding Assessment Score
10
PlaNeT-2 Inclusion criteria
  • Admission to a participating NICU (includes
    postnatal transfers)
  • lt34 weeks GA at birth
  • Platelet count of lt50 x109/L
  • Cranial ultrasound scan undertaken lt6 hours
    before randomisation to exclude recent major IVH

11
PlaNeT-2 Exclusion criteria
  • Major/life-threatening congenital malformations
  • Recent major haemorrhage within the last 72 hours
  • All fetal intracranial haemorrhages
  • Known immune thrombocytopenia
  • Neonates unlikely to survive
  • Neonates not given parenteral vitamin K

12
PlaNeT-2 Consent
When platelets lt100x109/L
Document on PlaNeT-2 log book
13
PlaNeT-2 Randomisation
When the consent is signed and platelets
lt50x109/L
14
FA Platelet transfusion information
15
F1 Pre-randomisation
16
F2 Eligibility for randomisation
17
F3 Current medical conditions And previous
major bleeds
18
F4 Randomisation
19
PlaNeT-2 Data collection (I)
20
F5 Bleeding Assessment Tool (BAT)
21
F6 Daily Platelet Count
22
F7 Weekly Data Collection
23
PlaNeT-2 Data collection (II)
F8
F9
F10
F13
F14
F15
24
F8 Platelet Transfusion Data
25
PlaNeT-2 NEC/Sepsis form
  • Necrotising enterocolitis Stage 2 defined as
    per Bells Criteria (Bell et al,1978)
  • Sepsis culture positive sepsis or culture
    negative sepsis where a course of at least 5 days
    of antibiotics is to be administered for proven
    or clinically-suspected sepsis.
  • All episodes of NEC and sepsis must be recorded
    on the adverse event form
  • A listing of adverse events will be reported six
    monthly to the Independent Data Monitoring
    Committee.

26
F9 NEC/Sepsis form
27
F10 Discontinuation of Treatment Allocation
28
PlaNeT-2 Major/Severe bleed form
  • All new major bleeding events will be reported to
    the CSU without disclosing allocation arm.
  • Each report will be forwarded to the Independent
    Data Monitoring Committee for review as soon as
    it is received at the CSU.
  • In cases of uncertainty the local team may
    contact one of the CIs or neonatal medical
    experts.


MAJOR BLEED FORM
Within one working day of becoming aware of an Major Bleed, please fax a completed Major Bleed form to the NHSBT/MRC CSU
Fax 01223 588136
29
F13 Major/Severe Bleed
30
PlaNeT-2 Serious Adverse Event (SAE)
A SAE is an adverse event that results
  • in death
  • is life-threatening
  • requires hospitalisation or prolongation of
    existing hospitalisation (including readmission
    within 28 study days if discharged home earlier)
  • there is a likelihood of persistent or
    significant disability or incapacity


SAE NOTIFICATION
Within one working day of becoming aware of an SAE, please fax a completed SAE form to the NHSBT/MRC CSU
Fax 01223 588136
31
F14 Serious Adverse Event
32
PlaNeT-2 Serious platelet transfusion related
adverse event
Data collected on serious transfusion related
adverse reactions/events will be based on current
definitions used by hospitals reporting to UK
national haemovigilance reporting schemes (SHOT
and MHRA).
  • These definitions cover the following
  • Incorrect blood component transfused
  • Acute transfusion reactions
  • Transfusion Related Acute Lung Injury (TRALI)
  • Transfusion transmitted infections, including
    bacterial transmission
  • Transfusion Associated Circulatory Overload (TACO)

33
F15 Serious platelet transfusion related
adverse event
34
PlaNeT-2 End of study
Data collection will cease when the baby is 38
weeks corrected gestational age or time of
discharge home
Cranial Ultrasound at End of Study (F11) End of
Study (F12)
35
F11 Cranial USS at the end of study
36
F12 End of study
37
PlaNeT-2 Transfer out of recruiting unit
  • Inform the local PlaNeT-2 team if neonate
    transferred out of recruiting unit
  • Keep all the forms, do not send them with the
    patient
  • If a cranial USS has no been done in the last 7
    days, please perform one before the baby leaves.

38
PlaNeT-2 Two years follow up
Thames Regional Perinatal Outcome Group/ Standard
Electronic Neonatal Database/ National Neonatal
Audit Programme (TRPG/SEND/NNAP) 2- year
corrected age outcome form
39
PlaNeT-2 Data Quality
  • Black ink
  • For platelet count use the date and time the
    sample is received in the lab
  • Do not leave blank fields, enter leading zeros
  • Any data incorrectly recorded must be crossed
    through with a single line and the correct value
    documented by the side. All corrections must be
    initialled and dated by the individual making the
    changes

40
PlaNeT-2 Data Quality Cranial USS
  • Check what you need to score from the CRFs
  • Follow the Units guidelines
  • Good quality shot of the right view
  • Ask for a second opinion to a senior staff if you
    need
  • PlaNeT-2 is a trial based on these USS so that
    all scans are reviewed at local level and
    overseen nationally.

41
PlaNeT-2 Communications
  • Local queries
  • For general trial queries contact Karen
    Willoughby copy Ana Mora.
  • For medical queries regarding transfusions, SAEs,
    grading major/severe bleeds or transfusion
    reactions contact Simon Stanworth, Anna Curley or
    Vidheya Venkatesh.

www.planet-2.com
42
Two criteria to put a babys sticker in the
PlaNeT-2 book
  • Baby born at less than 34 weeks GA
  • Platelets lt100

43
What is the right documentation of consent?
  • Three copies of the consent forms signed.
    Original in site file
  • Complete documentation of parental discussion in
    the notes

44
Our practice documenting
(Please add here examples of your current
documentation practice)
45
If the baby is consented and his platelets go up
to 52 then 51 and then 50 in next three days,
what should you do?
I should wait. As long as the platelet count is
50 or above, the baby can not be randomised.
46
Two places where you can find forms
  • In the PlaNeT-2 box behind the desk
  • Online at www.planet-2.com

47
Where are the details to access to
www.sealedenvelope.com?
In the PlaNeT-2 book
48
What is wrong with this data collection plan?
49
So, is this plan right now?
50
Is this a better plan then?
51
How can you know at glance what form is due to be
completed?
52
CRF Game
  • You will be given 4 CRF Forms
  • 5 Find 3 sets of mistakes
  • 6 - Which two corrections are right?
  • 7 - Can you find the two missing fields?
  • 9 What is missing?

53
Find the three sets of mistakes
54
Which two corrections are right?
55
Can you find the two missing fields?
56
(No Transcript)
57
The baby is transferred out of the Unit, three
things you should do
  • Inform the PlaNeT-2 team
  • Keep all the PlaNeT-2 forms
  • A cranial USS if none has been done in the last 7
    days

58
Where is the PlaNeT-2 box kept?
59
What should you do if an enrolled baby develops a
rectal bleeding?
Inform the PlaNeT-2 team. (A rectal bleeding is
a major bleed that should be reported as soon as
possible)
60
What should you do if a SAE happens?
  • Proceed as Trust protocol indicates for that
    situation
  • Inform the research team as soon as possible

61
If you are not sure, what two things you should
do?
  • Ask us!! We are here to support you.
  • Check on-line www.planet-2.com

62
Thank you!
Write a Comment
User Comments (0)
About PowerShow.com